Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control

被引:34
|
作者
Shin, Hee Young [1 ]
Joo, Eun Youn [2 ]
Kim, Seong Tae [3 ]
Dhong, Hun-Jong [4 ]
Cho, Jin Whan [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ctr Hlth Promot, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otolaryngol, Seoul 135710, South Korea
关键词
REM sleep behavior disorder; Parkinson's disease; Olfaction; CC-SIT; Transcranial sonography; TRANSCRANIAL SONOGRAPHY; DYSFUNCTION; ECHOGENICITY; SCINTIGRAPHY; TIME;
D O I
10.1007/s10072-012-1164-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Rapid eye movement (REM) sleep behavior disorder (RBD) is a preclinical feature of synucleinopathies, such as Parkinson's disease (PD).This study aimed to investigate the presence of potential early manifestations of parkinsonism, such as olfactory dysfunction and substantia nigra (SN) hyperechogenicity, in idiopathic RBD (iRBD) patients, PD patients and normal controls. We performed an olfactory function test using the cross-cultural smell identification test (CC-SIT) and midbrain transcranial sonography (TCS) in 15 patients with iRBD as confirmed by polysomnography, 30 patients with PD, and 30 normal controls. The CC-SIT scores of the iRBD patients and PD patients were significantly lower than those of the normal controls and similar between iRBD and PD (mean +/- A SD, 7.1 +/- A 2.2 and 7.6 +/- A 2.4 vs. 10.4 +/- A 1.2, respectively, p < 0.01). The sum of bilateral SN echosignals in the iRBD patients was greater than that of the normal controls but lower than that of the PD patients (0.29 +/- A 0.47, 0.11 +/- A 0.17 and 0.72 +/- A 0.41 cm(2), respectively, p < 0.01). In conclusion, we found that the concomitant abnormality of olfaction and increased SN echogenicity was more frequent in iRBD compared with normal control. Olfactory dysfunction and SN hyperechogenicity could be preclinical manifestations of parkinsonism in iRBD patients.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 50 条
  • [21] Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease
    Berg, Daniela
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (03) : 453 - 461
  • [22] Clinical Features in Parkinson's Disease Patients with Hyperechogenicity in Substantia Nigra: A Cross-Sectional Study
    Zhu, Sha
    Wang, Yaxi
    Jiang, Yinyin
    Gu, Ruxin
    Zhong, Min
    Jiang, Xu
    Shen, Bo
    Zhu, Jun
    Yan, Jun
    Pan, Yang
    Zhang, Li
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1593 - 1601
  • [23] Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor
    Sprenger, Fabienne S.
    Wurster, Isabel
    Seppi, Klaus
    Stockner, Heike
    Scherfler, Christoph
    Sojer, Martin
    Schmidauer, Christof
    Berg, Daniela
    Poewe, Werner
    MOVEMENT DISORDERS, 2016, 31 (04) : 579 - 583
  • [24] Substantia Nigra Hyperechogenicity as a Marker for Parkinson's Disease: A Population-Based Study
    Mahlknecht, Philipp
    Seppi, Klaus
    Stockner, Heike
    Nocker, Michael
    Scherfler, Christoph
    Kiechl, Stefan
    Willeit, Johann
    Schmidauer, Christoph
    Gasperi, Arno
    Rungger, Gregorio
    Poewe, Werner
    NEURODEGENERATIVE DISEASES, 2013, 12 (04) : 212 - 218
  • [25] Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: yes
    Daniela Berg
    Journal of Neural Transmission, 2011, 118 : 613 - 619
  • [26] The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study)
    Prati, Patrizio
    Bignamini, A.
    Coppo, L.
    Naldi, A.
    Comi, C.
    Cantello, R.
    Gusmaroli, G.
    Walter, U.
    JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (07) : 869 - 879
  • [27] Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra
    Akbas, Nilguen
    Hochstrasser, Helmine
    Deplazes, Joelle
    Tomiuk, Juergen
    Bauer, Peter
    Walter, Uwe
    Behnke, Stefanie
    Riess, Olaf
    Berg, Daniela
    NEUROSCIENCE LETTERS, 2006, 407 (01) : 16 - 19
  • [28] Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
    Berg, D
    Metz, B
    Reiners, K
    Naumann, M
    Becker, G
    MOVEMENT DISORDERS, 2005, 20 (03) : 383 - 385
  • [29] Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder
    Moren, C.
    Gonzalez-Casacuberta, I.
    Navarro-Otano, J.
    Juarez-Flores, D.
    Vilas, D.
    Garrabou, G.
    Milisenda, J. C.
    Pont-Sunyer, C.
    Catalan-Garcia, M.
    Guitart-Mampel, M.
    Tobias, E.
    Cardellach, F.
    Valldeoriola, F.
    Iranzo, A.
    Tolosa, E.
    PARKINSONS DISEASE, 2017, 2017
  • [30] Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis
    Shafieesabet, Azin
    Fereshtehnejad, Seyed-Mohammad
    Shafieesabet, Azadeh
    Delbari, Ahmad
    Baradaran, Hamid Reza
    Postuma, Ronald B.
    Lokk, Johan
    PARKINSONISM & RELATED DISORDERS, 2017, 42 : 1 - 11